Acquisitions and Divestitures (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Deconsolidated Assets and Liabilities

The following table presents Zymergen’s consolidated assets and liabilities which have been deconsolidated from the Company's consolidated balance sheet as of October 2, 2023. The amounts presented are before the elimination of intercompany balances.


	October 2, 2023
Assets
Current assets:
Cash and cash equivalents	$	34,321
Accounts receivable, net	11,047
Prepaid expenses and other current assets	11,190
Total current assets	56,558
Property, plant and equipment, net	8,938
Operating lease right-of-use assets	135,800
Intangible assets, net	16,679
Goodwill	10,660
Other non-current assets	19,486
Total assets	248,121
Liabilities
Current liabilities:
Deferred revenue	730
Accrued expenses and other current liabilities	20,426
Total current liabilities	21,156
Non-current liabilities:
Operating lease liabilities, non-current	184,301
Other non-current liabilities	172
Total liabilities	205,629
Net assets deconsolidated	$	42,492

The following table presents Zymergen’s results of operations for the periods presented, included in the Company's consolidated statements of operations and comprehensive loss prior to the elimination of intercompany balances.


	Period from January 1, 2023 - October 2, 2023
Total revenue	$	8,370
Total operating expenses	200,975
Loss from operations	(192,605)
Total other income, net	23,620
Loss before income taxes	(168,985)
Income tax provision	14
Net loss	$	(168,999)